secwatch.observer — SEC 8-K summary
======================================

Issuer:     ILLUMINA, INC. (ILMN)
CIK:        0001110803
Form:       8-K
Filed at:   2025-02-06T23:59:59+00:00
Accession:  0001110803-25-000014
Event type: earnings
Sentiment:  neutral
Materiality: 0.75
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Illumina Q4 core revenue up 1% to $1.1B; FY2025 guided to low single-digit growth
--------------------------------------------------------------------------------

- Core Illumina Q4 revenue $1.104B (+1% YoY); GAAP EPS $0.73, non-GAAP EPS $0.95.
- Full year core revenue $4.332B (-2% YoY); free cash flow $1.07B.
- FY2025 guidance: core revenue $4.28B-$4.4B; non-GAAP Op margin ~23%; non-GAAP EPS $4.50-$4.65.
- China Ministry of Commerce impact excluded from guidance; company notes current macro/political environment.
- Key partnerships announced: NVIDIA, UK Biobank proteomics, Regeneron/Truveta Genome Project.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1110803/000111080325000014/0001110803-25-000014-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1110803/000111080325000014/ilmn-20250206.htm
  HTML page:      https://secwatch.observer/filing/0001110803-25-000014

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer